Article info

Download PDFPDF
Bosentan therapy for patients with severe Raynaud’s phenomenon in systemic sclerosis
  1. Dr M E Hettema, Division of Rheumatology and Clinical Immunology, University Medical Center Groningen, PO Box 30001, 9700 RB Groningen, the Netherlands; m.e.hettema{at}int.umcg.nl
View Full Text

Citation

Hettema ME, Zhang D, Bootsma H, et al
Bosentan therapy for patients with severe Raynaud’s phenomenon in systemic sclerosis

Publication history

  • Accepted March 31, 2007
  • First published September 19, 2007.
Online issue publication 
September 19, 2007

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.